查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947500

藥物篩檢市場：依產品類型、樣本類型、技術、最終用戶和應用劃分－全球預測至2036年

Drug Screening Market by Product, Sample Type, Technology, End User, and Application -- Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 284 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球藥物篩檢市場預計將從2026年的82.9億美元成長到2036年的約253億美元，預測期內（2026-2036年）複合年增長率（CAGR）為11.8%。

本報告對全球五大主要地區的藥物篩檢市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至2036年的預測。透過廣泛的二級和一級研究以及對市場現狀的深入分析，我們分析了關鍵產業驅動因素、限制因素、機會和挑戰的影響。

推動藥物篩檢市場成長的關鍵因素包括：全球對工作場所安全的日益關注、綜合藥物濫用預防計畫的快速擴展，以及交通運輸和醫療機構對可靠檢測方法的需求不斷增長。 此外，口腔液檢測的廣泛應用、快速檢測系統的創新以及監管合規基礎設施的完善，預計將為藥物篩檢市場的企業創造巨大的成長機會。

市場區隔

目錄

第一章：引言

第二章：摘要整理

第三章：市場概覽

  • 市場動態
    • 驅動因素
    • 限制因素
    • 機遇
    • 挑戰
  • 監管變化和合成物質對藥物篩檢的影響
  • 監管環境與聯邦檢測標準
  • 波特五力分析

章節4. 全球藥物篩檢市場（依產品類型劃分）

  • 分析儀器
    • 免疫分析儀
    • 色譜儀
    • 質譜系統
  • 快速偵測儀器
    • 尿液檢測試劑盒
    • 口腔液檢測儀器
    • 檢測杯和浸漬卡
  • 耗材
    • 檢測試劑盒和試劑
    • 採樣裝置
    • 校準品和品管品
  • 服務
    • 實驗室服務
    • 工作場所檢測項目
    • 確證分析服務

第五章：全球藥物篩檢市場（依樣本類型劃分）

  • 尿液樣本
  • 口腔液樣本
  • 呼吸樣本
  • 毛髮樣本
  • 其他（血液、汗水）

第六章 全球藥物篩檢市場（依技術劃分）

  • 免疫分析法
    • 酵素連結免疫分析法
    • 放射免疫分析法
    • 螢光免疫分析法
  • 色譜法
    • 氣相層析質譜儀用法
    • 液相層析質譜儀用法
    • 高效液相層析法
  • 呼吸分析儀
    • 燃料電池技術
    • 半導體技術
  • 其他（光譜學、晶片實驗室）

第七章：全球藥物篩檢市場（依最終使用者劃分）

  • 工作場所
    • 入職前篩檢
    • 隨機檢測項目
    • 事故後偵測
  • 藥物檢測實驗室
  • 醫院和診所
  • 刑事司法與執法機構
  • 戒毒治療中心
  • 疼痛管理中心
  • 學校和教育機構
  • 其他（體育組織、個人使用者）

第八章：全球藥物篩檢市場（依應用劃分）

  • 藥物濫用檢測
    • 大麻檢測
    • 阿片類藥物檢測
    • 可卡因檢測
    • 安非他明檢測檢測
    • 合成藥物檢測
  • 酒精檢測
  • 其他（處方藥監測、運動興奮劑）

第九章 全球藥物篩檢市場（依地區劃分）

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 中東和非洲其他地區

第十章 競爭格局

  • 關鍵成長策略
  • 競爭標竿分析
  • 競爭概覽
    • 行業領導者
    • 市場差異化因素
    • 先鋒企業
    • 新興企業
  • 主要企業市場排名/定位分析（2025 年）

第11章 企業簡介(產業概要，財務概要，產品系列，策略性展開，SWOT分析)

  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings(LabCorp)
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Dragerwerk AG &Co. KGaA
  • OraSure Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Lifeloc Technologies, Inc.
  • Premier Biotech, Inc.
  • Omega Laboratories, Inc.
  • Psychemedics Corporation
  • Alfa Scientific Designs, Inc.
  • MPD Inc.

第12章 附錄

簡介目錄
Product Code: MRHC - 1041763

Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036

According to the research report titled, 'Drug Screening Market by Product (Analyzers, Rapid Testing Devices, Consumables, Services), Sample Type (Urine, Oral Fluid, Breath, Hair), Technology (Immunoassay, Chromatography, Breath Analyzers), End User (Workplace, Drug Testing Laboratories, Hospitals, Criminal Justice, Drug Treatment Centers), and Application (Drug of Abuse Testing, Alcohol Testing) - Global Forecast to 2036,' the global drug screening market is expected to reach approximately USD 25.3 billion by 2036 from USD 8.29 billion in 2026, at a CAGR of 11.8% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global drug screening market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the drug screening market include escalating global concern over workplace safety, rapid expansion of comprehensive substance abuse prevention programs, and increasing need for high-reliability detection in transportation and healthcare complexes. Additionally, proliferation of oral fluid testing, innovation in rapid testing systems, and regulatory compliance infrastructure development are expected to create significant growth opportunities for players operating in the drug screening market.

Market Segmentation

The drug screening market is segmented by product (analyzers, rapid testing devices, consumables, services), sample type (urine, oral fluid, breath, hair), technology (immunoassay, chromatography, breath analyzers), end user (workplace, drug testing laboratories, hospitals, criminal justice, drug treatment centers), application (drug of abuse testing, alcohol testing), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, the services segment holds the largest market share in 2026, particularly in supporting large-scale laboratory testing operations, comprehensive workplace programs, and superior analytical accuracy in forensic applications. Analyzers represent a significant segment for confirmatory testing and high-volume screening. Rapid testing devices are growing rapidly for point-of-care applications and on-site screening. Consumables represent a steady segment supporting ongoing testing operations.

Based on Sample Type

By sample type, the urine sample segment holds the largest market share in 2026, due to the widespread adoption of standardized testing protocols and established detection windows for diverse substance categories. Oral fluid represents a rapidly growing segment offering improved sample integrity and non-invasive collection. Breath and hair samples represent specialized segments for specific applications and extended detection windows.

Based on Technology

By technology, immunoassay dominates the market for rapid screening applications, offering cost-effectiveness and high-throughput capabilities. Chromatography represents a significant segment for confirmatory testing and complex substance detection. Breath analyzers represent a specialized segment for alcohol testing and impairment assessment. Advanced analytical technologies continue to evolve for improved detection accuracy and expanded substance coverage.

Based on End User

By end user, the workplace segment holds the largest share of the overall market in 2026, driven by stringent regulatory requirements and comprehensive occupational health protocols. Drug testing laboratories represent a significant segment for confirmatory testing and forensic applications. Hospitals, criminal justice systems, and drug treatment centers represent growing segments with specialized testing requirements and regulatory compliance needs.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America dominates the global drug screening market with the largest market share in 2026, driven by stringent workplace regulations and the presence of comprehensive federal testing programs in the United States and Canada. Asia-Pacific is expected to witness the fastest growth during the forecast period, supported by increasing awareness of substance abuse prevention and expanding workplace safety protocols in China, India, and Japan.

Key Players

The key players operating in the global drug screening market are Quest Diagnostics, LabCorp, Abbott Diagnostics, Thermo Fisher Scientific, Alere Inc., Roche Diagnostics, Siemens Healthcare Diagnostics, Bio-Rad Laboratories, Immunalysis Corporation, and Psychemedics Corporation, among others.

Key Questions Answered in the Report

  • How big is the global drug screening market?
  • What is the growth rate of the global drug screening market?
  • Which product segment will dominate and grow the fastest?
  • How are oral fluid testing and synthetic substance detection transforming the drug screening landscape?
  • Which region leads the global drug screening market?
  • Who are the major players in the global drug screening market?
  • What are the key trends shaping the drug screening market?
  • What are the major opportunities and challenges in the drug screening market?

Scope of the Report:

Drug Screening Market Assessment -- by Product

  • Analyzers
  • Rapid Testing Devices
  • Consumables
  • Services

Drug Screening Market Assessment -- by Sample Type

  • Urine
  • Oral Fluid
  • Breath
  • Hair

Drug Screening Market Assessment -- by Technology

  • Immunoassay
  • Chromatography
  • Breath Analyzers
  • Others

Drug Screening Market Assessment -- by End User

  • Workplace
  • Drug Testing Laboratories
  • Hospitals
  • Criminal Justice
  • Drug Treatment Centers

Drug Screening Market Assessment -- by Application

  • Drug of Abuse Testing
  • Alcohol Testing

Drug Screening Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Southeast Asia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Scope
  • 1.3. Research Methodology
  • 1.4. Assumptions & Limitations

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
    • 3.2.4. Challenges
  • 3.3. Impact of Regulatory Changes and Synthetic Substances on Drug Screening
  • 3.4. Regulatory Landscape & Federal Testing Standards
  • 3.5. Porter's Five Forces Analysis

4. Global Drug Screening Market, by Product

  • 4.1. Introduction
  • 4.2. Analyzers
    • 4.2.1. Immunoassay Analyzers
    • 4.2.2. Chromatography Instruments
    • 4.2.3. Mass Spectrometry Systems
  • 4.3. Rapid Testing Devices
    • 4.3.1. Urine Test Kits
    • 4.3.2. Oral Fluid Test Devices
    • 4.3.3. Test Cups & Dip Cards
  • 4.4. Consumables
    • 4.4.1. Assay Kits & Reagents
    • 4.4.2. Sample Collection Devices
    • 4.4.3. Calibrators & Controls
  • 4.5. Services
    • 4.5.1. Laboratory Testing Services
    • 4.5.2. Workplace Testing Programs
    • 4.5.3. Confirmatory Analysis Services

5. Global Drug Screening Market, by Sample Type

  • 5.1. Introduction
  • 5.2. Urine Sample
  • 5.3. Oral Fluid Sample
  • 5.4. Breath Sample
  • 5.5. Hair Sample
  • 5.6. Others (Blood, Sweat)

6. Global Drug Screening Market, by Technology

  • 6.1. Introduction
  • 6.2. Immunoassay
    • 6.2.1. Enzyme Immunoassay
    • 6.2.2. Radioimmunoassay
    • 6.2.3. Fluorescence Immunoassay
  • 6.3. Chromatography
    • 6.3.1. Gas Chromatography-Mass Spectrometry
    • 6.3.2. Liquid Chromatography-Mass Spectrometry
    • 6.3.3. High-Performance Liquid Chromatography
  • 6.4. Breath Analyzers
    • 6.4.1. Fuel Cell Technology
    • 6.4.2. Semiconductor Technology
  • 6.5. Others (Spectroscopy, Lab-on-a-Chip)

7. Global Drug Screening Market, by End User

  • 7.1. Introduction
  • 7.2. Workplace
    • 7.2.1. Pre-employment Screening
    • 7.2.2. Random Testing Programs
    • 7.2.3. Post-accident Testing
  • 7.3. Drug Testing Laboratories
  • 7.4. Hospitals & Clinics
  • 7.5. Criminal Justice & Law Enforcement Agencies
  • 7.6. Drug Treatment Centers
  • 7.7. Pain Management Centers
  • 7.8. Schools & Educational Institutions
  • 7.9. Others (Sports Organizations, Personal Users)

8. Global Drug Screening Market, by Application

  • 8.1. Introduction
  • 8.2. Drug of Abuse Testing
    • 8.2.1. Cannabis/Marijuana Testing
    • 8.2.2. Opioid Testing
    • 8.2.3. Cocaine Testing
    • 8.2.4. Amphetamine Testing
    • 8.2.5. Synthetic Drug Testing
  • 8.3. Alcohol Testing
  • 8.4. Others (Prescription Drug Monitoring, Sports Doping)

9. Global Drug Screening Market, by Region

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Netherlands
    • 9.3.7. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. India
    • 9.4.3. Japan
    • 9.4.4. South Korea
    • 9.4.5. Australia
    • 9.4.6. Southeast Asia
    • 9.4.7. Rest of Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America
  • 9.6. Middle East & Africa
    • 9.6.1. Saudi Arabia
    • 9.6.2. UAE
    • 9.6.3. South Africa
    • 9.6.4. Rest of Middle East & Africa

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Ranking / Positioning Analysis of Key Players, 2025

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)

  • 11.1. Quest Diagnostics Incorporated
  • 11.2. Laboratory Corporation of America Holdings (LabCorp)
  • 11.3. Abbott Laboratories
  • 11.4. Thermo Fisher Scientific Inc.
  • 11.5. F. Hoffmann-La Roche Ltd.
  • 11.6. Siemens Healthineers AG
  • 11.7. Dragerwerk AG & Co. KGaA
  • 11.8. OraSure Technologies Inc.
  • 11.9. Bio-Rad Laboratories, Inc.
  • 11.10. Lifeloc Technologies, Inc.
  • 11.11. Premier Biotech, Inc.
  • 11.12. Omega Laboratories, Inc.
  • 11.13. Psychemedics Corporation
  • 11.14. Alfa Scientific Designs, Inc.
  • 11.15. MPD Inc.

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Related Reports